Real-world characteristics, treatment patterns, and outcomes of patients with mantle cell lymphoma (MCL) after receiving covalent bruton tyrosine kinase inhibitors (cBTKi) in China
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Ningjing Lin, Yuqin Song, Xue Zhang, Guangdong Xie, Xiao Ma, Jun Zhu
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417017097
Cites:
Cited by:
Related to:
